Your browser doesn't support javascript.
loading
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.
Iveson, Timothy J; Sobrero, Alberto F; Yoshino, Takayuki; Souglakos, Ioannis; Ou, Fang-Shu; Meyers, Jeffrey P; Shi, Qian; Grothey, Axel; Saunders, Mark P; Labianca, Roberto; Yamanaka, Takeharu; Boukovinas, Ioannis; Hollander, Niels H; Galli, Fabio; Yamazaki, Kentaro; Georgoulias, Vassilis; Kerr, Rachel; Oki, Eiji; Lonardi, Sara; Harkin, Andrea; Rosati, Gerardo; Paul, James.
Afiliación
  • Iveson TJ; University of Southampton, Southampton, United Kingdom.
  • Sobrero AF; Ospedale Policlinico San Martino IRCCS, Genova, Italy.
  • Yoshino T; National Cancer Center Hospital East, Kashiwa, Japan.
  • Souglakos I; Department of Medical Oncology, University Hospital of Heraklion, Iraklio, Greece.
  • Ou FS; Mayo Clinic, Rochester, MN.
  • Meyers JP; Mayo Clinic, Rochester, MN.
  • Shi Q; Mayo Clinic, Rochester, MN.
  • Grothey A; West Cancer Center and Research Institute, Germantown, TN.
  • Saunders MP; Christie Hospital, Manchester, United Kingdom.
  • Labianca R; Cancer Center, Ospedale Papa Giovanni XXIII Bergamo, Bergamo, Italy.
  • Yamanaka T; Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan.
  • Boukovinas I; Bioclinic Thessaloniki, Thessaloniki, Greece.
  • Hollander NH; IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Galli F; IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Yamazaki K; Shizuoka Cancer Center, Shizuoka, Japan.
  • Georgoulias V; Hellenic Oncology Research Group, Athens, Greece.
  • Kerr R; University of Oxford, Oxford, United Kingdom.
  • Oki E; Kyushu University, Fukuoka, Japan.
  • Lonardi S; Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Harkin A; University of Glasgow, Institute of Cancer Sciences, Scotland, United Kingdom.
  • Rosati G; San Carlo Hospital, Potenza, Italy.
  • Paul J; University of Glasgow, Institute of Cancer Sciences, Scotland, United Kingdom.
J Clin Oncol ; 39(6): 631-641, 2021 02 20.
Article en En | MEDLINE | ID: mdl-33439695
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Quimioterapia Adyuvante Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Quimioterapia Adyuvante Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos